(Total Views: 815)
Posted On: 08/15/2020 1:06:26 AM
Post# of 153986
“The people dumping millions of shares are WARRANT HOLDERS, not shorts.”
Honestly, I can’t tell if you’re upset with warrant holders convering their shares or are just pointing out a fact. Either way, you can’t place blame on them as NP made financing deals with these warrants AND has been encouraging warrant holders to convert. Double edged sword: money goes to the company but the outstanding shares count increase.
What investors are also failing to identify as a contributing factor to the recent decrease in SP is the “COVID bubble” factor. Whether we like it or not, trading potential COVID therapeutics or vaccines became a trading strategy over the past couple of months. Traders have been moving from COVID stock to COVID stock as each gets hyped and starts making an SP increase. CYDY was no different. Now that the M2M data was released and EUA seems unlikely for that population, traders have moved on as interim data from the severe trial may not be available until late September or early October. And as COVID is not a hot topic as it use to be, COVID stocks aren’t as hot as they use to be. Is there some BP or short involvement? Could be, be the “COVID bubble” is a contributing factor, IMO.
Honestly, I can’t tell if you’re upset with warrant holders convering their shares or are just pointing out a fact. Either way, you can’t place blame on them as NP made financing deals with these warrants AND has been encouraging warrant holders to convert. Double edged sword: money goes to the company but the outstanding shares count increase.
What investors are also failing to identify as a contributing factor to the recent decrease in SP is the “COVID bubble” factor. Whether we like it or not, trading potential COVID therapeutics or vaccines became a trading strategy over the past couple of months. Traders have been moving from COVID stock to COVID stock as each gets hyped and starts making an SP increase. CYDY was no different. Now that the M2M data was released and EUA seems unlikely for that population, traders have moved on as interim data from the severe trial may not be available until late September or early October. And as COVID is not a hot topic as it use to be, COVID stocks aren’t as hot as they use to be. Is there some BP or short involvement? Could be, be the “COVID bubble” is a contributing factor, IMO.
(9)
(0)
